|
週次 |
日期 |
單元主題 |
|
第1週 |
|
General aspects
Provide basic terminology and concept, including optimization of lead compounds, structure–activity relationship, oral bioavailability, and pharmacokinetics |
|
第2週 |
|
General Aspects-
Provide basic terminology and concept, including optimization of lead compounds, structure–activity relationship, oral bioavailability, and pharmacokinetics |
|
第3週 |
03/03 |
Antibiotics and antibiotic resistance-Describe the discovery of penicillins and our long-standing battles against bacteria |
|
第4週 |
03/10 |
Antibiotics and antibiotic resistance-Describe the discovery of penicillins and our long-standing battles against bacteria |
|
第5週 |
03/17 |
Aspirins and nonsteroidal anti-inflammatory agents (NSAIDs)-What happen about the sour success of selective cox-2 inhibitors? |
|
第7週 |
03/31 |
Aspirins and nonsteroidal anti-inflammatory agents (NSAIDs)-What happen about the sour success of selective cox-2 inhibitors? |
|
第8週 |
04/07 |
Tyrosine kinase inhibitors as effective anti-cancer therapy :There are 518 kinases encoded in the human genome, how are specific kinases inhibited for therapeutic development? |
|
第9週 |
04/14 |
期中考週 |
|
第10週 |
04/21 |
Tyrosine kinase inhibitors as effective anti-cancer therapy : There are 518 kinases encoded in the human genome, how are specific kinases inhibited for therapeutic development?
(第一週分組報告 oral presentation 1) |
|
第11週 |
04/28 |
Hormone analogues as contraceptives and antiulcer agents : Describe the mode of action of (i) mifepristone (RU486) and (ii) histamine receptor antagonists (ranitidine). (第二週分組報告 oral presentation 2) |
|
第12週 |
05/05 |
Hormone analogues as contraceptives and antiulcer agents : Describe the mode of action of (i) mifepristone (RU486) and (ii) histamine receptor antagonists (ranitidine). (第三週分組報告 oral presentation 3) |
|
第13週 |
05/12 |
Targeting proteases: success, failures and future prospects : Historic review of ACE inhibitors (for the treatment of hypertension) and HIV protease inhibitors (for that of AIDS) (第四週分組報告 oral presentation 4) |
|
第14週 |
05/19 |
Targeting proteases: success, failures and future prospects : Historic review of ACE inhibitors (for the treatment of hypertension) and HIV protease inhibitors (for that of AIDS) (第五週分組報告 oral presentation 5) |
|
第15週 |
05/26 |
Protein drugs : Most of protein drugs are glycoproteins. Why are glycosylations so important? (第六週分組報告 oral presentation 6) |
|
第16週 |
06/02 |
Protein drugs : Most of protein drugs are glycoproteins. Why are glycosylations so important? (第七週分組報告 oral presentation 7) |
|
第17週 |
06/09 |
(Optional) Opium analgestics : Understand the mode of action associated with pain-killing and addition (第八週分組報告 oral presentation 8) |
|
第18週 |
06/16 |
期末考週 |